Quantum BioPharma gets FDA clearance for MS drug phase 2 trial
Go back to Quantum BioPharma gets FDA clearance for MS drug phase 2 trial| Quantum Technology Corp (NASDAQ: QNTM) | Delayed: 3.85 -0.15 (3.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.00 | 52 Week High | $2.00 | |||
| Open | $4.00 | 52 Week Low | $0.10 | |||
| Day High | $4.00 | P/E | N/A | |||
| Day Low | $3.80 | EPS | $0.00 | |||
| Volume | 193,384 | |||||
